论文部分内容阅读
以放免法测定肝炎肝硬化血清透明质酸(Hyaluronic acid,HA)122例。在肝炎中,HA 水平在344.5±180.3μg/L 以下,与肝脏受损程度呈正相关,慢活肝>慢迁肝>急性肝炎;肝硬化的 HA 水平(560.3±182.4μg/L)高于各型肝炎。在29例肝硬化中有26例HA 在500μg/L 以上者经 B 超证实,另3例 HA500μg/L 以下者 B 超未显示肝硬化改变;在26例 HA500μg/L 以上的肝硬化中有10例同时作 CT 检查,亦证实为肝硬化,有2例 HA 在500μg/L 以下经 CT 检查,有1例为肝硬化。从 HA 水平和 B 超、CT 对比分析中,提示肝病时如HA 水平超过500μg/L 时,应考虑有肝硬化的存在。
Radiofrequency ablation was used to detect 122 cases of Hyaluronic acid (HA) in liver cirrhosis. In hepatitis, the level of HA was below 344.5 ± 180.3μg / L, which was positively correlated with the extent of liver damage. The slow-living liver> slow-moving liver> acute hepatitis; the HA level of cirrhosis (560.3 ± 182.4μg / L) Hepatitis. In 29 cases of cirrhosis, 26 cases of HA in 500μg / L or more by B-ultrasound, the other 3 cases of HA500μg / L B-ultrasound showed no change in cirrhosis; 26 cases of HA500μg / L more than cirrhosis in 10 Case of simultaneous CT examination, also confirmed cirrhosis, 2 cases of HA at 500μg / L by CT examination, 1 case of cirrhosis. From the HA level and B-ultrasound, CT contrast analysis, suggesting that liver disease such as HA levels over 500μg / L, the presence of cirrhosis should be considered.